Céline Gongora

14.8k total citations · 1 hit paper
79 papers, 3.7k citations indexed

About

Céline Gongora is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Céline Gongora has authored 79 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 33 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Céline Gongora's work include Cancer therapeutics and mechanisms (9 papers), Cancer Genomics and Diagnostics (9 papers) and Epigenetics and DNA Methylation (7 papers). Céline Gongora is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), Cancer Genomics and Diagnostics (9 papers) and Epigenetics and DNA Methylation (7 papers). Céline Gongora collaborates with scholars based in France, United States and Netherlands. Céline Gongora's co-authors include Maguy Del Rio, Bruno Robert, Marc Ychou, Franck Molina, Florent Moulière, Alain R. Thierry, Nadir Mechti, Pierre Martineau, Caroline Mollévi and Lucile Espert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Céline Gongora

75 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

2014 530 citations Alain R. Thierry, Florent Moulière et al. profile →

Peers

Countries citing papers authored by Céline Gongora

Since Specialization

Citations

This map shows the geographic impact of Céline Gongora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Gongora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Gongora more than expected).

Fields of papers citing papers by Céline Gongora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Gongora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Gongora. The network helps show where Céline Gongora may publish in the future.

Co-authorship network of co-authors of Céline Gongora

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Gongora. A scholar is included among the top collaborators of Céline Gongora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Gongora. Céline Gongora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TopBP1 biomolecular condensates as a new therapeutic target in advanced-stage colorectal cancer 2025 ·eLife ·(unknown), Nadia Vezzio-Vié, (unknown), (unknown), Antoine Aze, (unknown), (unknown), (unknown), Hervé Seitz, (unknown), Véronique Garambois, Laurent Chaloin, Nathalie Bonnefoy, Céline Gongora, Angelos Constantinou, Jihane Basbous	0
2	Shining light on drug discovery: optogenetic screening for TopBP1 biomolecular condensate inhibitors 2025 ·NAR Cancer ·(unknown), Nadia Vié, (unknown), (unknown), Véronique Garambois, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jihane Basbous, Céline Gongora, Angelos Constantinou	0
3	Characterization of the cell-free DNA released by tumor organoids derived from colorectal cancer patients 2025 ·European Journal of Cancer ·(unknown), Jérôme Cartry, (unknown), Ekaterina Pisareva, Corinne Prévostel, Céline Gongora, (unknown), Antoine Italiano, Michel Ducreux, Alice Boilève, Jacques R.R. Mathieu, Fanny Jaulin, Alain R. Thierry	1
4	Efficacy of novel allogeneic cancer cells vaccine to treat colorectal cancer 2024 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Emeric Limagne, Marion Brun, (unknown), (unknown), (unknown), Céline Gongora, Lionel Apétoh, François Ghiringhelli	2
5	Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects 2022 ·Pharmaceutics ·Fanny Leenhardt, Frédéric Fiteni, (unknown), (unknown), Séverine Guiu, Nelly Firmin, Stéphane Pouderoux, Marie Viala, Gérald Lossaint, C. Gautier, Caroline Mollévi, (unknown), Céline Gongora, (unknown), Alexandre Evrard, William Jacot	9
6	Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells 2022 ·PLoS ONE ·Vincent Denis, (unknown), Maguy Del Rio, Emmanuel Cornillot, Nicole Bec, Christian Larroque, (unknown), Marta Jarlier, (unknown), Bruno Robert, Céline Gongora, Pierre Martineau, Piona Dariavach	6
7	Synthesis and in vitro antitumour activity of carboplatin analogues containing functional handles compatible for conjugation to drug delivery systems 2020 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Cyril Fersing, Céline Gongora, Jean‐Pierre Pouget, Vincent Lisowski	7
8	Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related ( ATR ) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer 2019 ·Cancer Research ·(unknown), Augusto Faria Andrade, Diégo Tosi, Henri‐Alexandre Michaud, Flavie Coquel, Véronique Garambois, (unknown), Marta Jarlier, Arnaud Coquelle, Philippe Pasero, Nathalie Bonnefoy, Jérôme Moreaux, Pierre Martineau, Maguy Del Rio, Roderick L. Beijersbergen, Nadia Vezzio-Vié, Céline Gongora	49
9	Use of physiological information based on grayscale images to improve mass spectrometry imaging data analysis from biological tissues 2019 ·Analytica Chimica Acta ·Sergi Mas, (unknown), Nicole Bec, Luis Fernández, (unknown), Céline Gongora, Christian Larroque, Pierre Martineau, Anna de Juan, Santiago Marco	9
10	FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer 2016 ·British Journal of Cancer ·Laetitia Marzi, (unknown), Nadia Vié, (unknown), Diégo Tosi, (unknown), (unknown), Christel Larbouret, Clara Montagut, Mar Iglesias, Marta Jarlier, Vincent Denis, Laëtitia K. Linares, Eric W.‐F. Lam, Pierre Martineau, Maguy Del Rio, Céline Gongora	44
11	FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance 2015 ·Molecular Cancer ·David Westover, Xiang Ling, Hong Lam, (unknown), Chunyang Jin, Céline Gongora, Maguy Del Rio, Mansukh C. Wani, Fengzhi Li	55
12	BAG6/BAT3 modulates autophagy by affecting EP300/p300 intracellular localization 2014 ·Autophagy ·Salwa Sebti, Christine Prébois, (unknown), Chantal Bauvy, Fabienne Desmots, Nelly Pirot, Céline Gongora, (unknown), Andrew V. Hubberstey, Valérie Palissot, Guy Berchem, Patrice Codogno, Laëtitia K. Linares, Emmanuelle Liaudet‐Coopman, Sophie Pattingre	29
13	Personalized Medicine by Analyzing Circulating DNA: Application to the Management Care of Colorectal Cancer Patients 2013 ·Annals of Oncology ·Florent Moulière, Safia El Messaoudi, Céline Gongora, Pierre‐Jean Lamy, Maguy Del Rio, Evelyne Lopez‐Crapez, Brigitte Gillet, Muriel Mathonnet, Denis Pezet, Marc Ychou, Alain R. Thierry	1
14	High Fragmentation Characterizes Tumour-Derived Circulating DNA 2011 ·PLoS ONE ·Florent Moulière, Bruno Robert, (unknown), Maguy Del Rio, Marc Ychou, Franck Molina, Céline Gongora, Alain R. Thierry	413
15	New Topoisomerase I mutations are associated with resistance to camptothecin 2011 ·Molecular Cancer ·Céline Gongora, Nadia Vezzio-Vié, Sandie Tuduri, Vincent Denis, Annick Causse, Céline Auzanneau, Gwenaëlle Collod‐Béroud, Arnaud Coquelle, Philippe Pasero, Philippe Pourquier, Pierre Martineau, Maguy Del Rio	56
16	Expression of βA3/A1-crystallin in the developing and adult rat eye 2011 ·Journal of Molecular Histology ·Geetha Parthasarathy, Bo Ma, Cheng Zhang, Céline Gongora, J. Samuel Zigler, Melinda K. Duncan, Debasish Sinha	25
17	Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma 2010 ·Cancer Research ·Salomé Paillas, Florence Boissière‐Michot, Frédéric Bibeau, (unknown), Caroline Mollévi, Annick Causse, Vincent Denis, Nadia Vezzio-Vié, Laetitia Marzi, Cédric Cortijo, Imade Aït-Arsa, Nadav Askari, Philippe Pourquier, Pierre Martineau, Maguy Del Rio, Céline Gongora	76
18	Prognostic significance of TRAIL-R1 and TRAIL-R3 expression in metastatic colorectal carcinomas 2008 ·European Journal of Cancer ·V. Granci, Frédéric Bibeau, Andrew Kramar, Florence Boissière‐Michot, Simon Thézenas, (unknown), Céline Gongora, Pierre Martineau, Maguy Del Rio, Marc Ychou	22
19	Downregulation of class II transactivator (CIITA) expression by synthetic cannabinoid CP55,940 2003 ·Immunology Letters ·Céline Gongora, Stacey Hose, Terrence P. O’Brien, Debasish Sinha	6
20	Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element 2002 ·Molecular and Cellular Biology ·Takeshi Kuwata, Céline Gongora, Yuka Kanno, Kazuyasu Sakaguchi, Tomohiko Tamura, Tomohiko Kanno, Venkatesha Basrur, Robert Martinez, Ettore Appella, Todd R. Golub, Keiko Ozato	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact